Birgitta Sander

About me
Publications
CV
Public outreach and news

About me

Birgitta Sander is a Professor of Pathology at the Department of Laboratory Medicine since 2011. Her research is mainly about Mantle cell lymphoma (MCL), which is a form of aggressive cancer that affects the lymphatic system.

Articles

Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025;26(5):2209
Targeting Tumor Microenvironment Interactions in Chronic Lymphocytic Leukemia Using Leukotriene Inhibitors
Sadeghi L; Merrien M; Bjorkholm M; Osterborg A; Sander B; Claesson H-E; Wright APH
Article: BLOOD. 2024;144(11):1221-1229
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes
Sirenko M; Bernard E; Creignou M; Domenico D; Farina A; Ossa JEA; Kosmider O; Hasserjian R; Jadersten M; Germing U; Sanz G; van de Loosdrecht AA; Gurnari C; Follo MY; Thol F; Zamora L; Pinheiro RF; Pellagatti A; Elias HK; Haase D; Sander B; Orna E; Zoldan K; Eder LN; Sperr WR; Thalhammer R; Ganster C; Ades L; Tobiasson M; Palomo L; Della Porta MG; Huberman K; Fenaux P; Belickova M; Savona MR; Klimek VM; Santos FPS; Boultwood J; Kotsianidis I; Santini V; Sole F; Platzbecker U; Heuser M; Valent P; Finelli C; Voso MT; Shih L-Y; Ogawa S; Fontenay M; Jansen JH; Cervera J; Ebert BL; Bejar R; Greenberg PL; Gattermann N; Malcovati L; Cazzola M; Beck DB; Hellstrom-Lindberg E; Papaemmanuil E
Article: CANNABIS AND CANNABINOID RESEARCH. 2024;9(3):e839-e846
Δ⁹-THC and CBD in Plasma, Oral Fluid, Exhaled Breath, and Urine from 23 Patients Administered Sativex
Melen CM; Merrien M; Wasik AM; Sander B; Wahlin BE; Panagiotis G; Beck O
Article: BLOOD. 2024;143(19):1953-1964
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma
Morsy MHA; Lilienthal I; Lord M; Merrien M; Wasik AM; Sureda-Gomez M; Amador V; Johansson HJ; Lehtio J; Garcia-Torre B; Martin-Subero JI; Tsesmetzis N; Tao S; Schinazi RF; Kim B; Sorteberg AL; Wickstrom M; Sheppard D; Rassidakis GZ; Taylor IA; Christensson B; Campo E; Herold N; Sander B
Article: LEUKEMIA & LYMPHOMA. 2024;65(4):534-537
Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy
Harrysson S; Eloranta S; Ekberg S; Enblad G; Andersson P-O; Sonnevi K; Ljungqvist M; Sander B; Jerkeman M; Smedby KE
Article: LEUKEMIA. 2024;38(2):610-620
Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis
Ren W; Wan H; Abd Own S; Berglund M; Wang X; Yang M; Li X; Liu D; Ye X; Sonnevi K; Enblad G; Amini R-M; Sander B; Wu K; Zhang H; Wahlin BE; Smedby KE; Pan-Hammarstrom Q
Article: LEUKEMIA & LYMPHOMA. 2023;64(12):1927-1937
Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy
Leich E; Brodtkorb M; Schmidt T; Altenbuchinger M; Lingjaerde OC; Lockmer S; Holte H; Nedeva T; Grieb T; Sander B; Sundstroem C; Spang R; Kimby E; Rosenwald A
Article: CLINICAL CANCER RESEARCH. 2023;29(20):4256-4267
Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts
Todisco G; Creignou M; Bernard E; Bjorklund A-C; Moura PL; Tesi B; Mortera-Blanco T; Sander B; Jansson M; Walldin G; Barbosa I; Reinsbach SE; Hofman IJ; Nilsson C; Yoshizato T; Dimitriou M; Chang D; Olafsdottir S; Larsson SV; Tobiasson M; Malcovati L; Woll P; Jacobsen SEW; Papaemmanuil E; Hellstroem-Lindberg E
Journal article: HEMASPHERE. 2023;7(Suppl):e5045724
PB1920: TARGETING THE TUMOR MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA USING LEUKOTRIENE INHIBITORS
Sadeghi L; Merrien M; Bjorkholm M; Sander B; Claesson H; Wright A
Article: ISCIENCE. 2023;26(6):106864
ADAR1-mediated RNA editing promotes B cell lymphomagenesis
Pecori R; Ren W; Pirmoradian M; Binder M; Papavasiliou N; Wang X; Liu D; Berglund M; Li W; Tasakis RN; Di Giorgio S; Ye X; Li X; Wu K; Helm D; Arnold A; Wust S; Schneider M; Selvasaravanan K-D; Fuell Y; Stafforst T; Amini R-M; Sonnevi K; Enblad G; Sander B; Wahlin BE; Zhang H; Papavasiliou FN; Pan-Hammarstrom Q
Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41 Suppl 2:302-303
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
Ren W; Own SA; Wan H; Berglund M; Wang X; Yang M; Li X; Liu D; Sonnevi K; Enblad G; Amini R; Sander B; Wu K; Zhang H; Wahlin BE; Smedby KE; Pan-Hammarström Q
Article: HISTOPATHOLOGY. 2023;82(7):1105-1111
Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium
Natkunam Y; de Jong D; Farinha P; Gaulard P; Klapper W; Rosenwald A; Sander B; Tooze R; Advani R; Burton C; Gribben JG; Kersten M-J; Kimby E; Lenz G; Molina T; Morschhauser F; Scott D; Sehn L; Stevens W; Clear A; Baia M; Habi A; Elsensohn M-H; Langlois-Jacques C; Maucort-Boulch D; Calaminici M
Article: CANCERS. 2023;15(5):1585
2-Arachidonoylglycerol Modulates CXCL12-Mediated Chemotaxis in Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
Merrien M; Wasik AM; Melen CM; Morsy MHA; Sonnevi K; Junlen H-R; Christensson B; Wahlin BE; Sander B
Article: FRONTIERS IN ONCOLOGY. 2023;13:1176698
Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study
Haider Z; Wasterlid T; Spangberg LD; Rabbani L; Jylha C; Thorvaldsdottir B; Skaftason A; Awier HN; Krstic A; Gellerbring A; Lyander A; Hagglund M; Jeggari A; Rassidakis G; Sonnevi K; Sander B; Rosenquist R; Tham E; Smedby KE
Article: PHARMACEUTICS. 2022;14(10):2238
A ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells
Ghaderi A; Zhong W; Okhovat MA; Aschan J; Svensson A; Sander B; Schultz J; Olin T; Osterborg A; Hojjat-Farsangi M; Mellstedt H
Article: BLOOD ADVANCES. 2022;6(18):5403-5414
Genomic characterization of lymphomas in patients with inborn errors of immunity
Ye X; Maglione PJ; Wehr C; Li X; Wang Y; Abolhassani H; Deripapa E; Liu D; Borte S; Du L; Wan H; Ploetner A; Giannoula Y; Ko H-B; Hou Y; Zhu S; Grossman JK; Sander B; Grimbacher B; Hammarstrom L; Fedorova A; Rosenzweig SD; Shcherbina A; Wu K; Warnatz K; Cunningham-Rundles C; Pan-Hammarstrom Q
Article: BLOOD ADVANCES. 2022;6(18):5482-5493
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
Los-deVries GT; Stevens WBC; van Dijk E; Langois-Jacques C; Clear AJ; Stathi P; Roemer MGM; Mendeville M; Hijmering NJ; Sander B; Rosenwald A; Calaminici M; Hoster E; Hiddemann W; Gaulard P; Salles G; Horn H; Klapper W; Xerri L; Burton C; Tooze RM; Smith AG; Buske C; Scott DW; Natkunam Y; Advani R; Sehn LH; Raemaekers J; Gribben J; Kimby E; Kersten MJ; Maucort-Boulch D; Ylstra B; de Jong D
Article: BLOOD. 2022;140(11):1229-1253
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Campo E; Jaffe ES; Cook JR; Quintanilla-Martinez L; Swerdlow SH; Anderson KC; Brousset P; Cerroni L; de Leval L; Dirnhofer S; Dogan A; Feldman AL; Fend F; Friedberg JW; Gaulard P; Ghia P; Horwitz SM; King RL; Salles G; San-Miguel J; Seymour JF; Treon SP; Vose JM; Zucca E; Advani R; Ansell S; Au W-Y; Barrionuevo C; Bergsagel L; Chan WC; Cohen JI; d'Amore F; Davies A; Falini B; Ghobrial IM; Goodlad JR; Gribben JG; Hsi ED; Kahl BS; Kim W-S; Kumar S; LaCasce AS; Laurent C; Lenz G; Leonard JP; Link MP; Lopez-Guillermo A; Mateos MV; Macintyre E; Melnick AM; Morschhauser F; Nakamura S; Narbaitz M; Pavlovsky A; Pileri SA; Piris M; Pro B; Rajkumar V; Rosen ST; Sander B; Sehn L; Shipp MA; Smith SM; Staudt LM; Thieblemont C; Tousseyn T; Wilson WH; Yoshino T; Zinzani P-L; Dreyling M; Scott DW; Winter JN; Zelenetz A
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;198(2):267-277
Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients
Harrysson S; Eloranta S; Ekberg S; Enblad G; El-Galaly TC; Sander B; Sonnevi K; Andersson P-O; Jerkeman M; Smedby KE
Article: LEUKEMIA & LYMPHOMA. 2022;63(6):1387-1397
Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia
Melen CM; Merrien M; Wasik AM; Panagiotidis G; Beck O; Sonnevi K; Junlen H-R; Christensson B; Sander B; Wahlin BE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;196(6):1362-1368
Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non-Waldenstrom macroglobulinemia type: A Swedish lymphoma registry study
Brandefors L; Sander B; Lundqvist K; Kimby E
Article: VIRCHOWS ARCHIV. 2022;480(3):655-666
Clinical and biological impact of SAMHD1 expression in mantle cell lymphoma
Merrien M; Wasik AM; Ljung E; Morsy MHA; Rodrigues JDM; Carlsten M; Rassidakis GZ; Christensson B; Kolstad A; Jerkeman M; Ek S; Herold N; Wahlin BE; Sander B
Article: CANCERS. 2022;14(5):1186
Sting Is Commonly and Differentially Expressed in T- and Nk-Cell but Not B-Cell Non-Hodgkin Lymphomas
Xagoraris I; Farrajota Neves da Silva P; Kokaraki G; Stathopoulou K; Wahlin B; Osterborg A; Herold N; Ng S-B; Medeiros LJ; Drakos E; Sander B; Rassidakis GZ
Article: PROSTAGLANDINS & OTHER LIPID MEDIATORS. 2021;156:106575
Intrinsic 5-lipoxygenase activity regulates migration and adherence of mantle cell lymphoma cells
Xia C; Sadeghi L; Straat K; Merrien M; Wright AP; Sander B; Xu D; Osterborg A; Bjorkholm M; Claesson H-E
Article: MEDICAL ONCOLOGY. 2021;38(6):70
The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas
Tesfa D; Sander B; Lindkvist H; Nilsson C; Kimby E; Hagglund H; Wahlin BE; Klimkowska M; Palmblad J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;106(2):290-293
Graft-versus-mastocytosis effect after donor lymphocyte infusion: Proof of principle
Hagglund H; Yavuz AS; Dreimane A; Malm C; Sundin A; Sander B; Nilsson G
Article: EJHAEM. 2020;1(1):199-207
Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survival
Skare TP; Sjoberg E; Berglund M; Smith RO; Roche FP; Lindskog C; Sander B; Glimelius I; Gholiha AR; Enblad G; Amini R-M; Claesson-Welsh L
Article: CANCERS. 2020;12(5):1143
Differential B-Cell Receptor Signaling Requirement for Adhesion of Mantle Cell Lymphoma Cells to Stromal Cells
Sadeghi L; Arvidsson G; Merrien M; Wasik AM; Gorgens A; Smith CIE; Sander B; Wright AP
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(4):707-717
Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy
Menter T; Tzankov A; Zucca E; Kimby E; Hultdin M; Sundstrom C; Beiske K; Cogliatti S; Banz Y; Cathomas G; Katjalainen-Lindsberg M-L; Grobholz R; Mazzucchelli L; Sander B; Hawle H; Hayoz S; Dirnhofer S
Article: LEUKEMIA. 2020;34(1):271-282
A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes
Elvarsdottir EM; Mortera-Blanco T; Dimitriou M; Bouderlique T; Jansson M; Hofman IJF; Conte S; Karimi M; Sander B; Douagi I; Woll PS; Hellstrom-Lindberg E
Article: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(35):3359-3368
Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium
Rosenwald A; Bens S; Advani R; Barrans S; Copie-Bergman C; Elsensohn M-H; Natkunam Y; Calaminici M; Sander B; Baia M; Smith A; Painter D; Pham L; Zhao S; Ziepert M; Jordanova ES; Molina TJ; Kersten MJ; Kimby E; Klapper W; Raemaekers J; Schmitz N; Jardin F; Stevens WBC; Hoster E; Hagenbeek A; Gribben JG; Siebert R; Gascoyne RD; Scott DW; Gaulard P; Salles G; Burton C; de Jong D; Sehn LH; Maucort-Boulch D
Journal article: HEMATOLOGICAL ONCOLOGY. 2019;37(S2):572
THE CANNABINOID STUDY – 01: INVESTIGATING THE EFFECTS OF CANNABINOIDS IN INDOLENT LEUKEMIC B‐CELL LYMPHOMA
Melén CM; Merrien M; Wasik AM; Sonnevi K; Junlén H; Christensson B; Sander B; Wahlin BE
Journal article: HEMASPHERE. 2019;3(S1):490-491
PS1082 PROGNOSTIC SIGNIFICANCE OF SAMHD1 EXPRESSION IN DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)
Xagoraris I; Herold N; Sander B; Smedby KE; Rassidakis G
Article: PEDIATRIC TRANSPLANTATION. 2019;23(4):e13408
Strong expression of p53 protein in bone marrow samples after hematopoietic stem cell transplantation indicates risk of relapse in pediatric acute lymphoblastic leukemia patients
Mattsson K; Honkaniemi E; Ramme K; Barbany G; Sander BM; Gustafsson BM
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2019;185(4):708-712
Expression of GNAZ, encoding the Gα_z protein, predicts survival in mantle cell lymphoma
Mundt F; Merrien M; Nygren L; Sutton LA; Christensson B; Wahlin BE; Rosenquist R; Sander B; Wasik AM
Journal article: BLOOD. 2018;132(Supplement 1):4136
SAMHD1 Is Variably Expressed in Mantle Cell Lymphoma and Correlated to SOX11 but Not to Survival
Wasik AM; Marin E; Merrien M; de Matos Rodrigues J; Lord M; Xagoraris I; Christensson B; Rassidakis G; Jerkeman M; Ek S; Sander B
Article: SCIENTIFIC REPORTS. 2018;8(1):15841
Single-Stranded Nucleic Acids Regulate TLR3/4/7 Activation through Interference with Clathrin-Mediated Endocytosis
Jarver P; Dondalska A; Poux C; Sandberg A; Bergenstrahle J; Skold AE; Dereuddre-Bosquet N; Martinon F; Palsson S; Zaghloul E; Brodin D; Sander B; Lennox KA; Behlke MA; EL-Andaloussi S; Lehtio J; Lundeberg J; LeGrand R; Spetz A-L
Article: BLOOD ADVANCES. 2018;2(6):621-625
Clinical and functional impact of recurrent S1PR1 mutations in mantle cell lymphoma
Wasik AM; Wu C; Mansouri L; Rosenquist R; Pan-Hammarstrom Q; Sander B
Article: HAEMATOLOGICA. 2018;103(4):666-678
Mixed-species RNAseq analysis of human lymphoma cells adhering to mouse stromal cells identifies a core gene set that is also differentially expressed in the lymph node microenvironment of mantle cell lymphoma and chronic lymphocytic leukemia patients
Arvidsson G; Henriksson J; Sander B; Wright AP
Journal article: BLOOD. 2017;130(Suppl_1):822
The Impact of Upfront Autologous Transplant on the Survival of Adult Patients with ALCL and PTCL-NOS According to Their ALK, DUSP22 and TP63 Gene Rearrangement Status - a Joined Nordic Lymphoma Group and Mayo Clinic Analysis
Pedersen MB; Relander T; Lauritzsen GF; Ellin F; Leppä S; Mannisto S; Jantunen E; Ketterling RP; Bedroske P; Luoma I; Sattler C; Delabie JMA; Sundstrom C; Sander B; Karjalainen-Lindsberg M-L; Hamilton-Dutoit S; Ehinger M; Vornanen M; Ralfkiaer E; Boddicker R; Bennani NN; Oishi N; Moeller MB; Noergaard P; Cerhan JR; Maurer MJ; Liestol K; Toldbod H; Feldman AL; d'Amore F
Article: HAEMATOLOGICA. 2017;102(8):1413-1423
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium
Stevens WBC; Mendeville M; Redd R; Clear AJ; Bladergroen R; Calaminici M; Rosenwald A; Hoster E; Hiddemann W; Gaulard P; Xerri L; Salles G; Klapper W; Pfreundschuh M; Jack A; Gascoyne RD; Natkunam Y; Advani R; Kimby E; Sander B; Sehn LH; Hagenbeek A; Raemaekers J; Gribben J; Kersten MJ; Ylstra B; Weller E; de Jong D
Article: AMERICAN JOURNAL OF PATHOLOGY. 2017;187(7):1454-1458
Numerous Ontogenetic Roads to Mantle Cell Lymphoma Immunogenetic and Immunohistochemical Evidence
Pouliou E; Xochelli A; Kanellis G; Stalika E; Sutton L-A; Navarro A; Agathangelidis A; Dimosthenous K; Anagnostopoulos A; Patsouris E; Korkolopoulou P; Sundstrom C; Ghia P; Ponzoni M; Sander B; Campo E; Rosenquist R; Hadzidimitriou A; Stamatopoulos K; Papadaki T
Journal article: BLOOD. 2016;128(22):5338
Immune Cell Dynamics in Nordic FL Patients in the SAKK 35/10 Randomized Trial with Rituximab and Lenalidomide
Lockmer S; Wahlin BE; Ostenstad B; Jeppson-Ahlberg Å; Sander B; Kimby E
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2016;175(1):102-114
The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era
Blaker YN; Spetalen S; Brodtkorb M; Lingjaerde OC; Beiske K; Ostenstad B; Sander B; Wahlin BE; Melen CM; Myklebust JH; Holte H; Delabie J; Smeland EB
Journal article: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2016;16:s111-s112
Immune Cell Modulations in Nordic FL Patients After Lenalidomide in the SAKK 35/10 Trial
Lockmer S; Jeppsson-Ahlberg Å; Sander B; Kimby E; Wahlin B
Article: ONCOTARGET. 2016;7(25):38180-38190
Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations
Wu C; de Miranda NFCC; Chen L; Wasik AM; Mansouri L; Jurczak W; Galazka K; Dlugosz-Danecka M; Machaczka M; Zhang H; Peng R; Morin RD; Rosenquist R; Sander B; Pan-Hammarstrom Q
Article: ACTA DERMATO-VENEREOLOGICA. 2016;96(5):602-612
Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus
Broesby-Olsen S; Dybedal I; Gulen T; Kristensen TK; Moller MB; Ackermann L; Saaf M; Karlsson M; Agertoft L; Brixen K; Hermann P; Stylianou E; Mortz CG; Torfing T; Havelund T; Sander B; Bergstrom A; Bendix M; Garvey LH; Weis Bjerrum O; Valent P; Bindslev-Jensen C; Nilsson G; Vestergaard H; Hagglund H
Article: EPIGENETICS. 2016;11(5):335-343
Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression
Kopparapu PK; Bhoi S; Mansouri L; Arabanian LS; Plevova K; Pospisilova S; Wasik AM; Croci GA; Sander B; Paulli M; Rosenquist R; Kanduri M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2015;171(4):478-490
Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts
Conte S; Katayama S; Vesterlund L; Karimi M; Dimitriou M; Jansson M; Mortera-Blanco T; Unneberg P; Papaemmanuil E; Sander B; Skoog T; Campbell P; Walfridsson J; Kere J; Hellstrom-Lindberg E
Article: PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS. 2015;100:33-40
Phosphorylation of serine 523 on 5-lipoxygenase in human B lymphocytes
Mahshid Y; Markoutsa S; Dincbas-Renqvist V; Sueruen D; Christensson B; Sander B; Bjorkholm M; Sorg BL; Radmark O; Claesson H-E
Article: PEERJ. 2015;3:e1056
Influence of rimonabant treatment on peripheral blood mononuclear cells; flow cytometry analysis and gene expression profiling
Almestrand S; Wang X; Jeppsson-Ahlberg A; Nordgren M; Flygare J; Christensson B; Rossner S; Sander B
Article: JOURNAL OF EXPERIMENTAL MEDICINE. 2015;212(6):833-843
Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
Mansouri L; Sutton L-A; Ljungstrom V; Bondza S; Arngarden L; Bhoi S; Larsson J; Cortese D; Kalushkova A; Plevova K; Young E; Gunnarsson R; Falk-Sorqvist E; Lonn P; Muggen AF; Yan X-J; Sander B; Enblad G; Smedby KE; Juliusson G; Belessi C; Rung J; Chiorazzi N; Strefford JC; Langerak AW; Pospisilova S; Davi F; Hellstrom M; Jernberg-Wiklund H; Ghia P; Soderberg O; Stamatopoulos K; Nilsson M; Rosenquist R
Article: LEUKEMIA & LYMPHOMA. 2015;56(5):1425-1431
Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma
Wasik AM; Priebe V; Lord M; Jeppsson-Ahlberg A; Christensson B; Sander B
Article: ONCOGENE. 2015;34(10):1231-1240
High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma
Kuo P-Y; Leshchenko VV; Fazzari MJ; Perumal D; Gellen T; He T; Iqbal J; Baumgartner-Wennerholm S; Nygren L; Zhang F; Zhang W; Suh KS; Goy A; Yang DT; Chan W-C; Kahl BS; Verma AK; Gascoyne RD; Kimby E; Sander B; Ye BH; Melnick AM; Parekh S
Article: CLINICAL CANCER RESEARCH. 2014;20(23):6096-6104
T-Cell Levels Are Prognostic in Mantle Cell Lymphoma
Nygren L; Wasik AM; Baumgartner-Wennerholm S; Jeppsson-Ahlberg A; Klimkowska M; Andersson P; Buhrkuhl D; Christensson B; Kimby E; Wahlin BE; Sander B
Article: ONCOSCIENCE. 2014;1(8):550-557
Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features.
Wasik AM; Nygren L; Almestrand S; Zong F; Flygare J; Wennerholm SB; Saft L; Andersson P; Kimby E; Wahlin BE; Christensson B; Sander B
Article: ACTA DERMATO-VENEREOLOGICA. 2014;94(5):583-584
Increased Risk of Malignant Melanoma in Patients with Systemic Mastocytosis?
Hagglund H; Sander B; Gulen T; Lindelof B; Nilsson G
Article: CLINICAL AND EXPERIMENTAL ALLERGY. 2014;44(9):1179-1187
The presence of mast cell clonality in patients with unexplained anaphylaxis
Gulen T; Hagglund H; Sander B; Dahlen B; Nilsson G
Article: MEDICAL ONCOLOGY. 2014;31(8):123
Analysis of V600E BRAF and D816V KIT mutations in systemic mastocytosis
Hagglund H; Sander B; Ahmadi A; Gulen T; Nilsson G
Article: PEDIATRIC HEMATOLOGY AND ONCOLOGY. 2014;31(4):327-339
Elevated p53 Protein Expression; A Predictor of Relapse in Rare Chronic Myeloid Malignancies in Children?
Honkaniemi E; Mattsson K; Barbany G; Sander B; Gustafsson B
Article: HAEMATOLOGICA. 2014;99(4):715-725
The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium
Sander B; de Jong D; Rosenwald A; Xie W; Balague O; Calaminici M; Carreras J; Gaulard P; Gribben J; Hagenbeek A; Kersten MJ; Molina TJ; Lee A; Montes-Moreno S; Ott G; Raemaekers J; Salles G; Sehn L; Thorns C; Wahlin BE; Gascoyne RD; Weller E
Article: BLOOD. 2014;123(13):2054-2061
Inhibition of lymphoma vascularization and dissemination by estrogen receptor β agonists
Yakimchuk K; Hasni MS; Guan J; Chao MP; Sander B; Okret S
Article: LEUKEMIA & LYMPHOMA. 2014;55(2):288-295
Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy
Wahlin BE; Sundstrom C; Sander B; Christensson B; Jeppsson-Ahlberg A; Hjalmarsson E; Holte H; Ostenstad B; Brown PD; Smeland EB; Kimby E
Article: EPIGENETICS. 2013;8(12):1280-1288
A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma
Kanduri M; Sander B; Ntoufa S; Papakonstantinou N; Sutton L; Stamatopoulos K; Kanduri C; Rosenquist R
Article: CLINICAL AND TRANSLATIONAL ALLERGY. 2013;3(1):22
The significance of diagnosing associated clonal mast cell diseases in patients with venom-induced anaphylaxis and the role of bone marrow investigation.
Gülen T; Dahlén B; Sander B; Hägglund H; Nilsson G
Article: SCIENTIFIC REPORTS. 2013;3:1400
SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression
Wasik AM; Lord M; Wang X; Zong F; Andersson P; Kimby E; Christensson B; Karimi M; Sander B
Article: MEDICAL ONCOLOGY. 2012;29(5):3540-3546
Systemic mastocytosis: progressive evolution of an occult disease into fatal mast cell leukemia: unique findings on an unusual hematological neoplasm
Gulen T; Sander B; Nilsson G; Palmblad J; Sotlar K; Horny H-P; Hagglund H
Article: STEM CELLS AND DEVELOPMENT. 2012;21(17):3147-3151
Treatment of Familial Hemophagocytic Lymphohistiocytosis with Third-Party Mesenchymal Stromal Cells
Mougiakakos D; Machaczka M; Jitschin R; Klimkowska M; Entesarian M; Bryceson YT; Henter J-I; Sander B; Le Blanc K
Article: CANCER RESEARCH. 2012;72(20):5307-5316
Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features
Navarro A; Clot G; Royo C; Jares P; Hadzidimitriou A; Agathangelidis A; Bikos V; Darzentas N; Papadaki T; Salaverria I; Pinyol M; Puig X; Palomero J; Carmela Vegliante M; Amador V; Martinez-Trillos A; Stefancikova L; Wiestner A; Wilson W; Pott C; Jose Calasanz M; Trim N; Erber W; Sander B; Ott G; Rosenwald A; Colomer D; Gine E; Siebert R; Lopez-Guillermo A; Stamatopoulos K; Bea S; Campo E
Article: BLOOD. 2012;119(18):4215-4223
Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma
Nygren L; Wennerholm SB; Klimkowska M; Christensson B; Kimby E; Sander B
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(4):557-564
Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy
von Bahr L; Sundberg B; Lonnies L; Sander B; Karbach H; Hagglund H; Ljungman P; Gustafsson B; Karlsson H; Le Blanc K; Ringden O
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2012;87(4):361-367
Mantle cell lymphoma displays a homogenous methylation profile: A comparative analysis with chronic lymphocytic leukemia
Halldorsdottir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Goransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
Article: BLOOD CANCER JOURNAL. 2012;2(1):e52
Entourage: the immune microenvironment following follicular lymphoma
Wahlin BE; Sander B; Christensson B; Ostenstad B; Holte H; Brown PD; Sundstrom C; Kimby E
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2012;156(2):225-233
Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times
Wahlin BE; Yri OE; Kimby E; Holte H; Delabie J; Smeland EB; Sundstrom C; Christensson B; Sander B
Article: PLOS ONE. 2012;7(2):e31366
Inhibition of the Intrinsic but Not the Extrinsic Apoptosis Pathway Accelerates and Drives Myc-Driven Tumorigenesis Towards Acute Myeloid Leukemia
Hoegstrand K; Hejll E; Sander B; Rozell B; Larsson L-G; Grandien A
Article: JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2011;33(8):e363-e367
Acute Respiratory Failure in 3 Children With Juvenile Myelomonocytic Leukemia
Gustafsson B; Hellebostad M; Ifversen M; Sander B; Hasle H
Journal article: BLOOD. 2011;118(21):3651
SOX11 Expression Versus Indolent Clinical Course in Mantle Cell Lymphomas in a Population-Based Cohort From the Stockholm Region – SOX11 Negative Tumors Are Mostly p53 Positive, Contributing to Shorter Overall Survival,
Sander B; Klimkowska M; Nygren L; Baumgartner S; Christensson B; Kimby E
Journal article: BLOOD. 2011;118(21):1592
Prognostic Impact of Clinical and Tumor Associated Variables in a Population-Based Cohort of Mantle Cell Lymphomas in the Stockholm Region Between 1998–2010
Wennerholm SB; Klimkowska M; Nygren L; Kimby E; Sander B
Journal article: BLOOD. 2011;118(21):1641
Increasing Grades of Follicular Lymphoma Correlate with Better Prognosis in Patients Treated with Rituximab
Wahlin BE; Sundström C; Holte H; Sander B; Østenstad B; de Nully Brown P; Smeland EB; Delabie J; Christensson B; Kimby E
Article: CELL DEATH & DISEASE. 2011;2(11):e225
WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells
Wasik AM; Almestrand S; Wang X; Hultenby K; Dackland A-L; Andersson P; Kimby E; Christensson B; Sander B
Journal article: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2011;11:s238
4.28 FISH on Paraffin-Embedded Tissue Samples is Feasible and of Prognostic Importance in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Norin S; Wallblom A; Sander B; Kimby E
Article: ACTA PAEDIATRICA. 2011;100(10):e186-e189
Maintenance of remission with cyclosporine in paediatric patients with Kimura's disease - two case reports
Soeria-Atmadja S; Oskarsson T; Celci G; Sander B; Berg U; Gustafsson B
Article: BLOOD. 2011;118(11):3088-3095
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases
Hadzidimitriou A; Agathangelidis A; Darzentas N; Murray F; Delfau-Larue M-H; Pedersen LB; Navarro Lopez A; Dagklis A; Rombout P; Beldjord K; Kolstad A; Dreyling MH; Anagnostopoulos A; Tsaftaris A; Mavragani-Tsipidou P; Rosenwald A; Ponzoni M; Groenen P; Ghia P; Sander B; Papadaki T; Campo E; Geisler C; Rosenquist R; Davi F; Pott C; Stamatopoulos K
Article: SEMINARS IN DIAGNOSTIC PATHOLOGY. 2011;28(3):245-255
Mantle cell lymphoma: recent insights into pathogenesis, clinical variability, and new diagnostic markers
Sander B
Article: ARTHRITIS & RHEUMATOLOGY. 2011;63(8):2209-2214
Late-Onset Neutropenia Following Rituximab Therapy in Rheumatic Diseases: Association With B Lymphocyte Depletion and Infections
Tesfa D; Ajeganova S; Hagglund H; Sander B; Fadeel B; Hafstrom I; Palmblad J
Article: BLOOD. 2011;117(26):7070-7078
Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium
Salles G; de Jong D; Xie W; Rosenwald A; Chhanabhai M; Gaulard P; Klapper W; Calaminici M; Sander B; Thorns C; Campo E; Molina T; Lee A; Pfreundschuh M; Horning S; Lister A; Sehn LH; Raemaekers J; Hagenbeek A; Gascoyne RD; Weller E
Article: CLINICAL CANCER RESEARCH. 2011;17(12):4136-4144
T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab
Wahlin BE; Sundstrom C; Holte H; Hagberg H; Erlanson M; Nilsson-Ehle H; Linden O; Nordstrom M; Ostenstad B; Geisler CH; Brown PDN; Lehtinen T; Maisenholder M; Tierens AM; Sander B; Christensson B; Kimby E
Article: GENES CHROMOSOMES & CANCER. 2011;50(2):113-121
High-Resolution Genomic Screening in Mantle Cell Lymphoma-Specific Changes Correlate with Genomic Complexity, the Proliferation Signature and Survival
Halldorsdottir AM; Sander B; Goransson H; Isaksson A; Kimby E; Mansouri M; Rosenquist R; Ehrencrona H
Article: PLOS ONE. 2010;5(11):e14085
Gene Expression Profiling and Chromatin Immunoprecipitation Identify DBN1, SETMAR and HIG2 as Direct Targets of SOX11 in Mantle Cell Lymphoma
Wang X; Bjoerklund S; Wasik AM; Grandien A; Andersson P; Kimby E; Dahlman-Wright K; Zhao C; Christensson B; Sander B
Journal article: BLOOD. 2010;116(21):536
Genome-Wide Array-Based Methylation Profiling Reveals Preferential Methylation of Homeobox Transcription Factor Genes In Mantle Cell Lymphoma and Pro-Apoptotic Genes In Chronic Lymphocytic Leukemia
Halldorsdottir AM; Kanduri M; Marincevic M; Göransson H; Isaksson A; Mansouri M; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
Journal article: BLOOD. 2010;116(21):4618
Cytogenetic Abnormalities In the Spleen In CLL Patients.
Norin S; Wallblom A; Aggarwal M; Sander B; Kimby E
Article: CLINICAL CANCER RESEARCH. 2010;16(2):637-650
A Unifying Microenvironment Model in Follicular Lymphoma: Outcome Is Predicted by Programmed Death-1-Positive, Regulatory, Cytotoxic, and Helper T Cells and Macrophages
Wahlin BE; Aggarwal M; Montes-Moreno S; Francisco Gonzalez L; Roncador G; Sanchez-Verde L; Christensson B; Sander B; Kimby E
Journal article: BLOOD. 2009;114(22):3953
Several Immune Cell Subsets Are Associated with Outcome in the Microenvironment of Follicular Lymphoma.
Wahlin BE; Aggarwal M; Montes-Moreno S; Gonzalez LF; Roncador G; Sanchez-Verde L; Christensson B; Sander B; Kimby E
Article: JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2009;31(9):696-701
Expression of VEGF and VEGF Receptors in Childhood Precursor B-cell Acute Lymphoblastic Leukemia Evaluated by Immunohistochemistry
Diffner E; Gauffin F; Anagnostaki L; Nordgren A; Gustafsson B; Sander B; Gustafsson B; Persson JL
Article: MOLECULAR CANCER RESEARCH. 2009;7(7):1086-1098
Potentiation of Cannabinoid-Induced Cytotoxicity in Mantle Cell Lymphoma through Modulation of Ceramide Metabolism
Gustafsson K; Sander B; Bielawski J; Hannun YA; Flygare J
Journal article: JOURNAL OF CLINICAL PATHOLOGY. 2009;62(2):128-138
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium) (Retracted article. See vol. 65, pg. 861, 2012)
de Jong D; Xie W; Rosenwald A; Chhanabhai M; Gaulard P; Klapper W; Lee A; Sander B; Thorns C; Campo E; Molina T; Hagenbeek A; Horning S; Lister A; Raemaekers J; Salles G; Gascoyne RD; Weller E
Article: BMC IMMUNOLOGY. 2009;10:2
High expression of 5-lipoxygenase in normal and malignant mantle zone B lymphocytes
Mahshid Y; Lisy M-R; Wang X; Spanbroek R; Flygare J; Christensson B; Bjorkholm M; Sander B; Habenicht AJR; Claesson H-E
Article: PEDIATRIC HEMATOLOGY AND ONCOLOGY. 2009;26(1):48-56
EXPRESSION OF PTEN AND SHP1, INVESTIGATED FROM TISSUE MICROARRAYS IN PEDIATRIC ACUTE LYMPHOBLASTIC, LEUKEMIA
Gauffin F; Diffner E; Gustafsson B; Nordgren A; Wingren AG; Sander B; Persson JL; Gustafsson B
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2008;143(2):248-252
The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival
Wang X; Asplund AC; Porwit A; Flygare J; Smith CIE; Christensson B; Sander B
Article: INTERNATIONAL JOURNAL OF CANCER. 2008;123(5):1025-1033
Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation
Gustafsson K; Wang X; Severa D; Eriksson M; Kimby E; Merup M; Christensson B; Flygare J; Sander B
Article: AMERICAN JOURNAL OF CLINICAL PATHOLOGY. 2008;129(4):630-638
A subset of CD5-diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus
Ehinger M; Linderoth J; Christerisson B; Sander B; Cavallin-Stahl E
Article: MEDICAL ONCOLOGY. 2008;25(4):374-379
Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis
Tesfa D; Gelius T; Sander B; Kimby E; Fadeel B; Palmblad J; Hagglund H
Journal article: BLOOD. 2007;110(11):2611
Grading Follicular Lymphoma: No Difference between 1, 2 and 3a, but 3b Is Something Else.
Wahlin BE; Sander B; Christensson B; Kimby E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2007;104(27):11406-11411
Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q-syndrome patients
Pellagatti A; Jaedersten M; Forsblom A-M; Cattan H; Christensson B; Emanuelsson EK; Merup M; Nilsson L; Samuelsson J; Sander B; Wainscoat JS; Boultwood J; Helistroem-Lindberg E
Article: LEUKEMIA & LYMPHOMA. 2007;48(7):1344-1352
Characterization of genetic changes in MCL by interphase FISH on tissue sections
Sander B; Wallblom A; Ekroth A; Porwit A; Kimby E
Article: FREE RADICAL BIOLOGY AND MEDICINE. 2007;43(1):90-99
Redox-signaling transmitted in trans to neighboring cells by melanoma-derived TNF-containing exosomes
Soderberg A; Barral AM; Soderstrom M; Sander B; Rosen A
Article: JOURNAL OF CLINICAL ONCOLOGY. 2007;25(7):805-812
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: Validation of tissue microarray as a prerequisite for broad clinical applications - A study from the Lunenburg Lymphoma Biomarker Consortium
de Jong D; Rosenwald A; Chhanabhai M; Gaulard P; Klapper W; Lee A; Sander B; Thorns C; Campo E; Molina T; Norton A; Hagenbeek A; Horning S; Lister A; Raemaekers J; Gascoyne RD; Salles G; Weller E
Article: CLINICAL CANCER RESEARCH. 2007;13(2):388-397
CD8+T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma
Wahlin BE; Sander B; Christensson B; Kimby E
Journal article: BLOOD. 2006;108(11):855
Lenalidomide Up-Regulates SPARC and Inhibits In Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome Patients with 5q Deletion.
Pellagatti A; Jädersten M; Forsblom A-M; Cattan H; Christensson B; Emanuelsson EK; Merup M; Nilsson L; Samuelsson J; Sander B; Wainscoat JS; Boultwood J; Hellström-Lindberg E
Article: MOLECULAR PHARMACOLOGY. 2006;70(5):1612-1620
Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma
Gustafsson K; Christensson B; Sander B; Flygare J
Article: FEBS LETTERS. 2005;579(30):6885-6889
Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma
Flygare J; Gustafsson K; Kimby E; Christensson B; Sander B
Article: INTERNATIONAL JOURNAL OF CANCER. 2005;117(3):418-430
Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1
Sander B; Flygare J; Porwit-MacDonald A; Smith CIE; Emanuelsson E; Kimby E; Liden J; Christensson B
Article: MELANOMA RESEARCH. 2004;14(4):251-255
Germline CDKN2A mutations are rare in child and adolescent cutaneous melanoma
Berg P; Wennberg AM; Tuominen R; Sander B; Rozell BL; Platz A; Hansson J
Article: MEDICAL ONCOLOGY. 2004;21(3):273-284
Posttransplant lymphoma -: A single-center experience of 500 liver transplantations
Norin S; Kimby E; Ericzon BG; Christensson B; Sander B; Söderdahl G; Häggland H
Article: JOURNAL OF NEUROIMMUNOLOGY. 2003;145(1-2):115-126
Phenotypes indicating cytolytic properties of Borrelia-specific interferon-gamma secreting cells in chronic Lyme neuroborreliosis.
Ekerfelt C; Jarefors S; Tynngård N; Hedlund M; Sander B; Bergström S; Forsberg P; Ernerudh J
Article: LEUKEMIA. 2003;17(9):1880-1890
High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma
Islam TC; Asplund AC; Lindvall JM; Nygren L; Liden J; Kimby E; Christensson B; Smith CIE; Sander B
Article: BLOOD. 2003;101(10):4047-4054
Mutated V_H genes and preferential V_H3-21 use define new subsets of mantle cell lymphoma
Walsh SH; Thorsélius M; Johnson A; Söderberg O; Jerkernan M; Björck E; Eriksson I; Thunberg U; Landgren O; Ehinger M; Löfvenberg E; Wallman K; Enblad G; Sander B; Porwit-MacDonald A; Dictor M; Olofsson T; Sundström C; Roos G; Rosenquist R
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2002;34(10):759-762
IL-8 and tumor necrosis factor alpha in heart valves from patients with infective endocarditis.
Ekdahl C; Broqvist M; Franzén S; Ljunghusen O; Maller R; Sander B
Article: MELANOMA RESEARCH. 2000;10(4):331-343
Thioredoxin, thioredoxin reductase and tumour necrosis factor-α expression in melanoma cells:: correlation to resistance against cytotoxic attack
Barral AM; Källström R; Sander B; Rosén A
Article: INTERNATIONAL JOURNAL OF CANCER. 1999;80(5):646-651
Cutaneous malignant melanoma in Swedish children and teenagers 1973-1992: a clinico-pathological study of 130 cases.
Sander B; Karlsson P; Rosdahl I; Westermark P; Boeryd B
Article: ACTA DERMATO-VENEREOLOGICA. 1998;78(4):289-292
Increasing incidence of cutaneous malignant melanoma in children and adolescents 12-19 years of age in Sweden 1973-92.
Karlsson P; Boeryd B; Sander B; Westermark P; Rosdahl I
Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 1997;44(6):335-340
Variable expression of tumor necrosis factor alpha in human malignant melanoma localized by in situ hybridization for mRNA.
Bergenwald C; Westermark G; Sander B
Article: JOURNAL OF AUTOIMMUNITY. 1997;10(4):347-355
Effects of the murine genotype on T cell activation and cytokine production in murine mercury-induced autoimmunity.
Johansson U; Sander B; Hultman P
Article: MELANOMA RESEARCH. 1997;7(2):139-145
Effect of interferon-alpha on the expression of tumour necrosis factor-alpha by metastatic malignant melanoma in vivo.
Håkansson A; Gustafsson B; Krysander L; Bergenwald C; Sander B; Håkansson L
Article: JOURNAL OF UROLOGY. 1996;156(2):536-541
Localization of IL-1, IL-2, IL-4, IL-8 and TNF in superficial bladder tumors treated with intravesical Bacillus Calmette-Guerin
Sander B; Damm O; Gustafsson B; Andersson U; Hakansson L
Article: INTERNATIONAL JOURNAL OF CANCER. 1996;66(1):42-47
Tumor necrosis factor-alpha expression in human primary malignant malanoma and it relationship to tumor infiltration by CD3+ cells.
Sander B; Boeryd B
Article: IMMUNOLOGY. 1995;86(4):512-518
Sequential production of Th1 and Th2 cytokines in response to live Bacillus Calmette-Guerin
Sander B; SkansenSaphir U; Damm O; Hakansson L; Andersson J; Andersson U
Journal article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1994;39(4):380-386
HIV-1 INHIBITS LEISHMANIA-INDUCED CELL-PROLIFERATION BUT NOT PRODUCTION OF INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA
WOLDAY D; AKUFFO H; BRITTON S; HATHAWAY A; SANDER B
Journal article: JOURNAL OF IMMUNOLOGICAL METHODS. 1993;166(2):201-214
SIMILAR FREQUENCIES AND KINETICS OF CYTOKINE PRODUCING CELLS IN MURINE PERIPHERAL-BLOOD AND SPLEEN - CYTOKINE DETECTION BY IMMUNOASSAY AND INTRACELLULAR IMMUNOSTAINING
SANDER B; HOIDEN I; ANDERSSON U; MOLLER E; ABRAMS JS
Journal article: EUROPEAN JOURNAL OF IMMUNOLOGY. 1991;21(8):1887-1892
DIFFERENTIAL REGULATION OF LYMPHOKINE PRODUCTION IN MITOGEN-STIMULATED MURINE SPLEEN-CELLS
SANDER B; CARDELL S; MOLLER G; MOLLER E
Journal article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1991;33(3):287-296
INTERLEUKIN-4 AND INTERFERON-GAMMA PRODUCTION IN RESTIMULATED CD4+ AND CD8+ CELLS INDICATES MEMORY TYPE RESPONSIVENESS
SANDER B; CARDELL S; MOLLER E
Journal article: IMMUNOLOGICAL REVIEWS. 1991;119:65-93
ASSESSMENT OF CYTOKINES BY IMMUNOFLUORESCENCE AND THE PARAFORMALDEHYDE-SAPONIN PROCEDURE
SANDER B; ANDERSSON J; ANDERSSON U
Journal article: EOS RIVISTA DI IMMUNOLOGIA ED IMMUNOFARMACOLOGIA. 1990;10(4):115-116
DETECTION OF INDIVIDUAL INTERLEUKIN-PRODUCING CELLS BY FLOW-CYTOMETRY
ANDERSSON U; SANDER B; ANDERSSON J
Journal article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1989;30(3):315-320
DETECTION OF INDIVIDUAL INTERLEUKIN 4-PRODUCING AND GAMMA-INTERFERON-PRODUCING MURINE SPLEEN-CELLS AFTER ACTIVATION WITH T-CELL MITOGENS
SANDER B; CARDELL S; HEREMANS H; ANDERSSON U; MOLLER G
Journal article: IMMUNOLOGY LETTERS. 1989;20(2):115-120
DETECTION OF INDIVIDUAL INTERLEUKIN 2-PRODUCING CELLS AFTER ANTI-CD3 ANTIBODY ACTIVATION
ANDERSSON U; SANDER B
Journal article: EUROPEAN JOURNAL OF IMMUNOLOGY. 1988;18(12):2081-2084
CONCOMITANT PRODUCTION OF DIFFERENT LYMPHOKINES IN ACTIVATED T-CELLS
ANDERSSON U; SANDER B; ANDERSSON J; MOLLER G
Journal article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1986;23(4):435-440
INHIBITION OF INVITRO ALLOREACTIVITY BY CYCLOSPORINE-A - EVIDENCE FOR AN INTERINDIVIDUAL VARIATION IN SENSITIVITY
SANDER B; BRIGATI C; MOLLER E
Journal article: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 1985;7(3):285-302
CPH - 86, A HIGHLY PURIFIED PODOPHYLLOTOXIN, EFFICIENTLY SUPPRESSES INVIVO AND INVITRO IMMUNE-RESPONSES
BRIGATI C; SANDER B
Show more

Employments

Professor Emeritus/Emerita, Department of Laboratory Medicine, Karolinska Institutet, 2024-2025
Professor/Senior Physician, Department of Laboratory Medicine, Karolinska Institutet, 2011-2024

Degrees and Education

Docent, Karolinska Institutet, 2002

About me

Articles

Employments

Degrees and Education

News from KI

Events from KI